- 英文名称N,N-Bis[3-D-Gluconamidopropyl]Cholamide
- 中文名称(3a,5b,7a,12a)-N,N-双[3-(D-葡萄糖酰氨基)丙基]-3,7,12-三羟基胆甾烷-24-胺
- IUPAC名称(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxy-N-[3-[3-[[(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanoyl]amino]propyl-[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]hexanamide
- 其它别名BigCHAP
- CAS编号86303-22-2
- MFCD编号:MFCD00082541
- EINECS号:689-123-4
- FDA UNII编号:7MI8P70R4A
- 分子式:C42H75N3O16分子量:878.06
- 产品CID: 2503268
- 产品分类有机原料 → 脂质和类脂质分子 → 类固醇和类固醇衍生物
欧盟法规
C&L通报海关参考信息
- 2905122000-异丙醇
2905310000-1,2-乙二醇
2905320000-1,2-丙二醇
2905399001-1,3-丙二醇 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2012190064-A1
优先权日:2004-10-01
标题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
发明人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA
权利人:KUDLICKI WIESLAW ANTONI; KEPPETIPOLA SHIRANTHI; FLETCHER JULIA; GETBEHEAD ASHLEY ELAINE; KATZEN FEDERICO; VOZZA-BROWN LAURA; LIFE TECHNOLOGIES CORP
摘要:Compositions, methods and kits for in vitro systems for synthesis of biomolecules such as polypeptides, are provided herein. Cell extracts that provide enhanced yields of soluble proteins using in vitro protein synthesis methods are provided. The invention also includes methods for producing high yields of proteins by the addition of a feeding solution that includes amino acids and an energy source to an ongoing in vitro synthesis system. The invention also includes methods of using a high-yield in vitro synthesis system to produce large quantities of proteins with incorporated labeled amino acids for analysis by methods such as by NMR. The invention further includes vectors for enhanced production of proteins from nucleic acid templates using in vitro synthesis systems.
专利号:US-2024409571-A1
优先权日:2023-06-08
标 题:Chemoenzymatic synthesis of n-acetylated gangliosides and glycosphingosines
发明人:CHEN XI; YU HAI; MISHRA BIJOYANANDA; ZHENG ZIMIN; AGRAHARI ANAND KUMAR; GUCCHAIT ARIN
权利人:UNIV CALIFORNIA
摘要:Described herein are novel stable 9-N-, 8-N-, and 7-N-acetyl analogues of instable 9-O-acetyl, 8-O-acetyl, and 7-O-acetyl b-series gangliosides and glycosphingosines, including GD3, GD2, GD1b, GT1b, GQ1b, and their glycosphingosines. Chemoenzymatic methods for the production of the stable 9-N-, 8-N-, and 7-N-acetyl analogues are also described herein.
专利号:US-2009209032-A1
优先权日:2004-10-01
标 题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
专利号:WO-2024107474-A1
优先权日:2022-11-15
标 题 :Controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes
发明人:IRVINE DARRELL; HAMMOND PAULA; PIRES IVAN SUSIN
权利人:MASSACHUSETTS INST TECHNOLOGY
摘要:Methods of controlled lipid self-assembly for scalable manufacturing of next-generation immune stimulating complexes (ISCOMs) are described. The methods involve mixing one or more saponins, one or more lipids, one or more sterols, one or more additional adjuvants (e.g., TLR4 agonist), and optionally one or more antigens in the presence of a detergent. Typically, the mixing step is followed by an incubation step, a dilution and/or concentration step, and/or a filtration or dialysis step for removing detergent. Preferably, methods involve a tangential flow filtration (TFF) process suitable for scalable synthesis and Good Manufacturing Practice (GMP) production of highly homogeneous clinical-grade ISCOM-based adjuvants.
专利号:WO-2006039622-A2
优先权日:2004-10-01
标 题 :Feeding buffers, systems, and methods for in vitro synthesis of biomolecules
专利号:US-2025197905-A1
优先权日:2022-03-20
标 题:Legionaminic acid glycosyltransferases for chemoenzymatic synthesis of glycans and glycoconjugates
发明人:CHEN XI; YANG XIAOHONG; YU HAI; MISHRA BIJOYANANDA
权利人:UNIV CALIFORNIA
摘要:Provided herein are methods for preparing a glycan product containing legionaminic acid moieties and other nonulosonic acids. Also provided herein are legionaminic acid transferase fusion proteins and vaccine compositions containing glycan products prepared according to the described methods.